Lupin receives USFDA’s approval for generic Triamcinolone Acetonide Ointment

22 Oct 2018 Evaluate

Lupin has received approval for its Triamcinolone Acetonide Ointment USP, 0.1% from the United States Food and Drug Administration (FDA) to market a generic version of Mylan Pharmaceuticals, Inc.'s (Mylan) Triamcinolone Acetonide Ointment, 0.1%.

Lupin's Triamcinolone Acetonide Ointment USP, 0.1% is the generic version of Mylan's Triamcinolone Acetonide Ointment, 0.1%. It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses.

Triamcinolone Acetonide Ointment USP, 0.1% had annual sales of approximately USD 25.7 million in the US (IQVIA MAT June 2018).

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2168.00 -8.25 (-0.38%)
19-Jan-2026 09:51 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1656.20
Dr. Reddys Lab 1174.45
Cipla 1384.00
Zydus Lifesciences 860.10
Lupin 2168.00
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×